“We believe that we will be able to increase (production) significantly, and by March we will be producing at least 30 million doses per month (including overseas sites -
We expect much larger volumes, but this is the forecast for the moment, ”Dmitriev said.
He noted that he would like to be conservative in his assessments, and said that RDIF is working with a large number of partners to increase production.
Earlier it was reported that RDIF had submitted applications for approval of the Sputnik V vaccine to regulators in 40 countries.
Inna Dolzhikova, the head of the laboratory of the state collection of viruses at the Gamaleya Center, told URA.RU about the Sputnik V vaccine.